clinical study insights

Evidence for Cross-Resistance Among Current Treatments
Oncology

Evidence for Cross-Resistance Among Current Treatments

clinical study insights
By William K. Oh, MD
Gene Signature Predicts Survival Benefits With Immunotherapy for mCRPC
Oncology

Gene Signature Predicts Survival Benefits With Immunotherapy for mCRPC

clinical study insights
By William K. Oh, MD
Gene Assay May Help Identify Patients at Risk for Metastasis After Surgery/EBRT
Oncology

Gene Assay May Help Identify Patients at Risk for Metastasis After Surgery/EBRT

clinical study insights
By Glen Gejerman, MD
Assessing Rapid Treatment Response in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Oncology

Assessing Rapid Treatment Response in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)

clinical study insights
By Oliver Sartor, MD
Impact of Newly Approved Treatment Regimens on Practice Patterns in Pancreatic Cancer
Oncology

Impact of Newly Approved Treatment Regimens on Practice Patterns in Pancreatic Cancer

clinical study insights
By Thomas A. Abrams, MD
Load More